Chengdu Xingcheng

Chengdu Xingcheng Investment Group Co., Ltd. is an important "state-owned capital investment and operation company" and "international urban comprehensive development and operation operator" in Chengdu. In 2020, it ranked 308th among China's Top 500 Enterprises, 25th among China's Top 100 Strategic Emerging Industries* Enterprises, and 8th among China's Top 10 Fastest-growing Net Assets Enterprises. It is the first state-owned enterprise in central and western China to join the Davos World Economic Forum and has been rated as a National Best Practice Enterprise for Corporate Culture. As of the end of December 2020, the group's assets reached 792 billion yuan, achieving operating revenue of 95.4 billion yuan and total profit of 9.7 billion yuan for the full year of 2020. The group's main businesses include banking and finance, construction industry, urban development, healthcare, sports and tourism, and asset management, with over 35,000 employees. It holds controlling stakes in Chengdu Rural Commercial Bank, Tianjin Hongri Pharmaceutical Co., Ltd., and Zhonghua Geotechnical Co., Ltd., and has multiple innovation and entrepreneurship platforms such as the Sichuan Provincial Postdoctoral Practice Base. Its subordinate enterprises have continuously received honors including National Key High-tech Enterprise and National Technology Innovation Demonstration Enterprise. Currently, the group is vigorously promoting the construction of major projects such as Tianfu Greenway Jincheng Park, Chengdu Health Medical Center, comprehensive development of Chengdu Eastern New Area, the East-West City Axis, and the renovation of venues for the Universiade, striving to enter the Fortune Global 500 by 2022, with assets exceeding one trillion yuan and operating revenue surpassing 180 billion yuan.